Navigation Links
FDA Acts to Halt Marketing of Unapproved Codeine Sulfate Tablets
Date:10/13/2009

Four Companies Required to Stop Making and Distributing Illegal Opioid Pain Relievers

SILVER SPRING, Md., Oct. 13 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today warned four companies that they must stop marketing unapproved codeine sulfate tablets. These drugs are opioid analgesics, commonly called narcotics, that are widely used to treat pain.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

These particular products have not received FDA approval and the agency has no evidence that they are safe and effective. Another manufacturer, Roxane Laboratories, markets FDA-approved codeine sulfate tablets and is able to meet the demand for the drug. The FDA does not anticipate a supply problem for codeine sulfate tablets.

"Consumers deserve and expect that their drugs meet modern FDA standards for safety, effectiveness, labeling, and quality. Removing unapproved products that do not meet those standards is an FDA priority," said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research (CDER). "The FDA urges drug companies to ensure all drugs they make and market have appropriate FDA approval."

The names of the products and the manufacturers and distributors that received the warning letters are:

  • Codeine Sulfate Tablets, 30 mg, 60 mg - Lehigh Valley Technologies Inc., Allentown, Penn.
  • Codeine Sulfate Tablets, 30 mg, 60 mg - Cerovene Inc., Valley Cottage, N.Y.
  • Codeine Sulfate Tablets, 30 mg - Dava International Inc., Fort Lee, N.J.
  • Codeine Sulfate Tablets, 30 mg, 60 mg - Glenmark Generics Inc. USA, Mahwah, N.J.

Companies receiving the warning letters have 15 days to give the FDA a plan to discontinue marketing the unapproved drugs. Manufacturers have 90 days to cease manufacturing of new product, and distrib
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
2. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
3. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
4. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
5. Infant Formula Manufacturers Again under Ethical Cloud: Marketing Gimmick Linked to Serious Illnesses
6. Cell Therapeutics, Inc. (CTI) Submits European Marketing Authorization Application for XYOTAX(TM)
7. European Regulatory Agency Accepts Cell Therapeutics, Inc.s Marketing Authorization Application for XYOTAX(TM) for Lung Cancer for Review
8. AMT Prepares for Submission of Marketing Authorization Dossier for AMT-011 (Glybera(R))
9. Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event
10. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
11. FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... -- Zimmer Holdings, Inc. (NYSE and SIX: ZMH), a global leader ... at the Bank of America Merrill Lynch 2015 Health Care ... Vegas, Nevada on Wednesday, May 13, at 8 ... the presentation can be accessed via Zimmer,s Investor Relations website ... replay following the conference. About the Company Founded ...
(Date:5/6/2015)... YORK , May 6, 2015  The fairness ... or the "Company") by Alexion Pharmaceuticals, Inc. ("Alexion") is ... shareholder rights law firm, for possible breaches of fiduciary ... of Directors of GEVA for agreeing to sell the ... announced a definitive agreement for Alexion to acquire GEVA ...
(Date:5/6/2015)... 2015 China Biologic Products, Inc. (NASDAQ: CBPO, ... plasma-based biopharmaceutical company in China, today announced its unaudited ... First Quarter 2015 Financial Highlights ... increased by 25.0% to $70.4 million from $56.3 million ... profit increased by 18.9% to $45.9 million from $38.6 ...
Breaking Medicine Technology:WeissLaw LLP Investigates the Synageva Biopharma Corp. Acquisition 2China Biologic Reports Financial Results for the First Quarter of 2015 2China Biologic Reports Financial Results for the First Quarter of 2015 3China Biologic Reports Financial Results for the First Quarter of 2015 4China Biologic Reports Financial Results for the First Quarter of 2015 5China Biologic Reports Financial Results for the First Quarter of 2015 6China Biologic Reports Financial Results for the First Quarter of 2015 7China Biologic Reports Financial Results for the First Quarter of 2015 8China Biologic Reports Financial Results for the First Quarter of 2015 9China Biologic Reports Financial Results for the First Quarter of 2015 10China Biologic Reports Financial Results for the First Quarter of 2015 11China Biologic Reports Financial Results for the First Quarter of 2015 12China Biologic Reports Financial Results for the First Quarter of 2015 13China Biologic Reports Financial Results for the First Quarter of 2015 14China Biologic Reports Financial Results for the First Quarter of 2015 15China Biologic Reports Financial Results for the First Quarter of 2015 16China Biologic Reports Financial Results for the First Quarter of 2015 17China Biologic Reports Financial Results for the First Quarter of 2015 18
... many injections, in two pivotal Phase 3 trials, ... of sustained virologic response comparable to Pegasys (peginterferon ... comparable rates of serious and/or severe adverse events ... alfa-2a -- Submission of global marketing applications planned ...
... for the treatment of type 2 diabetesHAYWARD, Calif., April ... of patient accrual to a phase 1b clinical study ... study is being conducted at multiple centers in the ... with type 2 diabetes for a period of 4 ...
Cached Medicine Technology:Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 2Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 3Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 4Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 5Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 6Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 7Human Genome Sciences Reports Positive Late-Breaker Results at EASL from ACHIEVE Phase 3 Trials of Albuferon(R) in Patients with Chronic Hepatitis C 8Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 2Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes 3
(Date:5/6/2015)... With recent headlines about the kidnapping of Bossini ... men from Southern China, it is becoming apparent to people ... for them. This is especially true for High Net Worth ... attention through the property they own, the schools their children ... those individuals, families and companies that are at higher risk ...
(Date:5/6/2015)... The dates have been selected and ... Changers Summit 2015 , an Information & Technology for ... Communications. Join the international gathering September 17-19 at the ... leaders from around the globe will speak and train ... the developing world. , The theme of the two-and-a-half-day ...
(Date:5/6/2015)... With an estimated 300,000 New Jersey ... potentially dangerous health effects, the Horizon Foundation of New ... Easier with Asthma Management) – to improve awareness, education ... through a $500,000 foundation grant to the Boys & ... BEAM throughout the state. , “While asthma cannot be ...
(Date:5/6/2015)... RPS Revolution - a game for the whole family with ... Scissors game - is now taking pre-orders via Kickstarter. ... to learn rules from Rock Paper Scissors, families can now ... Revolution takes the best parts of Rock Paper Scissors ... set of three called Trios. Trios like a Knight, Princess, ...
(Date:5/6/2015)... exclusive hospital of the Tampa Bay Buccaneers, Florida Hospital hosted ... Stadium for all the “Bucs Babies” celebrating their first birthday. ... “Bucs Babies” program last year. , “It is always ... born at the Florida Hospitals here in our community, who ... my time participating in the festivities, interacting with the Bucs ...
Breaking Medicine News(10 mins):Health News:Pacific Prime China Now Offering Kidnapping & Ransom Insurance 2Health News:Second Annual Game Changers Summit Offers ICT4D Workshops to 'Harness Power of Technology for Global Good' 2Health News:Second Annual Game Changers Summit Offers ICT4D Workshops to 'Harness Power of Technology for Global Good' 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 2Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 3Health News:The Horizon Foundation for New Jersey and Boys & Girls Clubs in New Jersey Join Forces to Help Children with Asthma 4Health News:RPS Revolution Launches Kickstarter Campaign 2Health News:RPS Revolution Launches Kickstarter Campaign 3Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 2Health News:Florida Hospital and the Tampa Bay Buccaneers Celebrate “Bucs Babies” Who are Turning One this Month with a Party on the Pirate Ship 3
... University of Wisconsin-Madison Center of Excellence in Cancer Communication ... the online information services and the information provided by ... coming to terms with it. ,Breast cancer ... computer support groups and other interactive services are the ...
... to anthrax being confirmed from Koothattukulam in Ernakulam district, the ... of the disease.// ,Tests conducted on the samples ... died a few days back had confirmed that the cause ... department said., ,The tests were conducted at the Avian ...
... Annual Meeting of SNM in San Diego witnessed a ... molecular imaging and nuclear medicine branch// and this meeting ... days. ,“SNM continues to successfully offer a ... on new and evolving aspects of nuclear medicine and ...
... researchers led by Dr. Adam Godzik at the Burnham ... up the understanding of information gathered// from the human ... them over a three year period, this consortium, under ... to provide adequate support to scientists from Burnham and ...
... Atlantic University, the Center for Breast Care at the ... The Center for Diagnostic// Systems and Visualization at the ... aid clinicians in the diagnosis and treatment of breast ... a unique software platform utilizing computational clinical imaging techniques ...
... from the University of South Florida has reported that nicotine ... ,They explained in the August issue of the ... that cause cancer, and that nicotine itself isn't one of ... existing cancer cells. ,The new study has explained ...
Cached Medicine News:Health News:Cancer patients benefited by online information services and support groups 2Health News:SNM recognizes exemplary contributors in nuclear medicine 2Health News:Joint Center for Molecular Modeling Instituted by Burnham Institute for Medical Research & UC San Diego 2Health News:New Tool to Diagnose and Treat Breast Cancer 2Health News:New Tool to Diagnose and Treat Breast Cancer 3Health News:Research Finds That Nicotine Hastens The Growth Of Lung Cancer 2
... to block tear drainage through the canaliculus, synthetic ... eye symptoms:, Indicated for use in the ... eye components of various ocular surface diseases, May ... eye related complications and to enhance the retention ...
... Inserted into the punctal opening to block ... provide long-term relief of dry eye symptoms, ... of its own natural tears:, Low-profile ... Flexibility of cap design facilitates easy removal ...
... The distinctive low profile dome head combined ... patient comfort. The pointed nose design simplifies ... shelf firmly secures plug making dislocation less ... and eliminates premature plug release. SOFT PLUG ...
... Flow Controllers may be used ... too much. The tapered shaft ... vector force, keeping it snugly ... it can be monitored. Designed ...
Medicine Products: